Theratechnologies Inc (THERF) 0.4131

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Theratechnologies Inc (THERF) 0.4131 $THERF

Theratechnologies Announces Financial Results for Fiscal Year 2013
Marketwire - Thu Feb 27, 6:02AM CST
Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the year ended November 30, 2013.

Theratechnologies to Announce Financial Results for Fiscal Year 2013
Marketwire - Tue Feb 25, 4:01PM CST
Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the fiscal year ended November 30, 2013, on Thursday, February 27, 2014, before markets open.

Theratechnologies Inc.: Short Supply of EGRIFTA(R) Announced
Marketwire - Fri Feb 14, 5:01AM CST
Theratechnologies Inc. (TSX: TH) announced today that it expects current inventory of EGRIFTA(R) (tesamorelin for injection) to be depleted in the coming weeks due to a combination of manufacturing delays and issues observed during the production of new batches of EGRIFTA(R). The depletion of the inventory will result in a shortage of EGRIFTA(R) and an eventual stock-out. EMD Serono, Inc. has notified the United States Food and Drug Administration about this product shortage.

IIROC Trade Resumption - Theratechnologies Inc.
Newsfile Corp - Fri Dec 13, 7:46AM CST
Trading resumes in:

IIROC Trade Halt - Theratechnologies Inc.
Newsfile Corp - Fri Dec 13, 7:44AM CST
The following issues have been halted by IIROC:

Theratechnologies Regains U.S. Marketing Rights to EGRIFTA(R)
Marketwire - Fri Dec 13, 7:30AM CST
Theratechnologies Inc. (TSX: TH) today announced that it has reached an agreement with EMD Serono to regain all rights under the current collaboration and licensing agreement entered into in 2008 with EMD Serono, including commercialization rights for EGRIFTA(R) (tesamorelin for injection) in the United States.

Theratechnologies Resumes Shipment of Tesamorelin to EMD Serono
Marketwire - Tue Dec 03, 3:54PM CST
Theratechnologies Inc. (TSX: TH) is pleased to announce that it has resumed shipment of EGRIFTA(TM) (tesamorelin for injection) to EMD Serono in the United States today.

Mild Cognitive Impairment - Pipeline Review, H2 2013
M2 - Mon Nov 25, 2:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/5vvwc8/mild_cognitive) has announced the addition of the "Mild Cognitive Impairment - Pipeline Review, H2 2013" report to their offering. 'Mild Cognitive Impairment - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Mild Cognitive Impairment, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Mild Cognitive Impairment. Scope - A snapshot of the global therapeutic scenario for Mild Cognitive Impairment. - A review of the Mild Cognitive Impairment products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Mild Cognitive Impairment pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Mild Cognitive Impairment. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding Mild Cognitive Impairment pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. Companies Mentioned Boehringer Ingelheim GmbH Takeda Pharmaceutical Company Limited Chiesi Farmaceutici SpA Pfizer Inc. Paladin Labs Inc. Theratechnologies Inc. Suven Life Sciences Ltd. QR Pharma, Inc. For more information visit http://www.researchandmarkets.com/research/5v..._cognitive About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Jubilant HollisterStier Notifies Theratechnologies of Labour Disruption
Marketwire - Wed Nov 13, 4:30PM CST
Theratechnologies Inc. (TSX: TH) today announced that it has been informed by Jubilant HollisterStier (Jubilant), the third-party contract manufacturer for tesamorelin, that a strike has been initiated by employees working at its manufacturing site in Montreal, Canada.

Theratechnologies Inc.: Health Canada Agrees to Reconsider Tesamorelin
Marketwire - Fri Nov 01, 10:47AM CDT
Theratechnologies Inc. (TSX: TH) today announced that Health Canada has agreed to resume review of the tesamorelin New Drug Submission (NDS) and has rescinded the notice of non-compliance/withdrawal (NON/w) it issued in March 2013.

Abdominal Obesity - Pipeline Review, H2 2013
M2 - Fri Oct 11, 8:55AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rm9rd6/abdominal_obesity) has announced the addition of the "Abdominal Obesity - Pipeline Review, H2 2013" report to their offering. 'Abdominal Obesity - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Abdominal Obesity, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Abdominal Obesity. Scope - A snapshot of the global therapeutic scenario for Abdominal Obesity. - A review of the Abdominal Obesity products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Abdominal Obesity pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects. - Latest news and deals relating to the products. Reasons to buy - Identify and understand important and diverse types of therapeutics under development for Abdominal Obesity. - Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage. - Plan mergers and acquisitions effectively by identifying players of the most promising pipeline. - Devise corrective measures for pipeline projects by understanding Abdominal Obesity pipeline depth and focus of Indication therapeutics. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope. - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline. Companies Mentioned Theratechnologies Inc. Aileron Therapeutics, Inc. Lithera, Inc. For more information visit http://www.researchandmarkets.com/research/rm...al_obesity About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Theratechnologies Announces Financial Results for Third Quarter of 2013
Marketwire - Thu Oct 10, 6:01AM CDT
Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2013.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lake Ridge Sets $0.68 Dividend as 2026 Payouts Rise

Updated Category News Views 128

A community bank raising its cash return is not fireworks, but it gets my attention faster than another glossy growth slogan. Lake Ridge Bancorp has declared a fourth-quarter 2026 dividend of $0.68 per share, payable December 16 to shareholders of record on November 30. That is a plain, useful announcement from OTCQX:LRBI, and plain is often underrated when you are...

Continue Reading
Automotive Laminates: Small Market, Real EV Leverage

Updated Category News Views 126

Cabin trim has become a surprisingly serious battleground, and that is the whole point of this automotive laminates story. Nobody buys a vehicle because somebody bragged about a multilayer film behind the door panel. Yet the materials under the fingertips, beneath the carpet, and around the dashboard increasingly decide whether an interior feels cheap, quiet, durable, or...

Continue Reading
LNG’s Coming Glut Could Gut Global Trading Profits

Updated Category News Views 55

A five-year LNG surplus is the sort of forecast that makes people nod politely today and panic much too late. Bain & Company is putting a hard edge on that risk: the global trading profit pool could slide from an estimated $20 billion in 2026 to roughly $5.5 billion a year during a 2030–34 glut, then potentially tip below zero once cancellation costs bite. That is not a...

Continue Reading
MIND Takes Its Copilot Security Bet Across Microsoft 365

Updated Category News Views 92

Copilot’s promise gets a lot less charming the minute confidential files start wandering around unchecked. That is the knot MIND is trying to untie with its expanded, generally available integrations across Microsoft Copilot, Microsoft 365, Purview, Teams, SharePoint, OneDrive, Edge and Exchange. The Seattle data-loss-prevention company announced the collaboration on...

Continue Reading
Shenzhen Three-Way Summit Puts Stability to the Test

Updated Category News Views 7

Three nuclear powers sharing a room in Shenzhen is the sort of headline that makes every risk desk sit upright, even when the paperwork remains thin. CGTN reports that Chinese President Xi Jinping, Russian President Vladimir Putin and U.S. President Donald Trump met on November 19, 2026, in an unprecedented trilateral summit and issued a Declaration toward Peace. That is...

Continue Reading
Full Truck Alliance Profits Surge as Revenue Slows

Updated Category News Views 38

A freight platform just delivered the kind of earnings math that makes investors sit up: sales barely jogged, while profit took off running. Full Truck Alliance’s third-quarter report is plainly strong on the surface, with net income up 49.0% year over year to RMB1.37 billion. Still, this is not a clean, uncomplicated growth story. The quality of the margin jump...

Continue Reading
Cadence Marks $2.7 Million for St. Jude Family Care

Updated Category News Views 172

Small Wheels, Serious Purpose Tiny tricycles, flour-dusted bake-sale tables, and family pledges have pushed Cadence Education’s St. Jude partnership to $2.7 million since 2018. That number is not a flashy balance-sheet item, nor should anybody try to dress it up as one. It is the accumulated result of school communities showing up year after year, and in a sector built...

Continue Reading
Subaru's 650-Car Anniversary Bet Is Delightfully Small

Updated Category News Views 112

Gold brake calipers may sound like a fussy correction, yet that little detail tells you exactly who Subaru is trying to please. The company has revised its announcement for the 2027 WRX tS GD25 and BRZ tS ZC15, clarifying the anniversary-model names and changing the WRX description from red-painted to gold-painted Brembo calipers. Nobody should confuse a corrected paint...

Continue Reading
AIC Hotel Group's 11 Awards Test Resort Market Reach

Updated Category News Views 42

Eleven Trophies, Four Properties, One Useful Signal Hospitality awards can be a lot of polished brass and very little cash flow, but this batch is substantial enough to deserve a hard look. AIC Hotel Group collected 11 honors spanning Condé Nast Traveler's 2026 Readers' Choice Awards, Travel Weekly's 2026 Magellan Awards, and Good Housekeeping's 2027 Travel Awards. The...

Continue Reading
ROBOTERA Puts Humanoid Robots Into Logistics Night Work

Updated Category News Views 36

Midnight warehouse work is where a humanoid robot has to quit posing and earn its keep. ROBOTERA arrived at the 2026 APEC CEO Summit with a useful answer to the usual shiny-robot nonsense: it says its machines are already working in logistics centers, handling parcel induction and taking on repetitive, physically demanding shifts that people understandably do not line up...

Continue Reading

Top 5 Most Recently Viewed Articles

WM Technology Faces Class Action Lawsuit: What Investors Need to Know

Updated Category News Views 69

Understanding WM Technology's Legal Challenges WM Technology, Inc. has recently found itself at the center of a class action lawsuit, raising significant concerns among its investors. This legal action has been initiated by a prominent law firm advocating for shareholder rights, highlighting serious allegations against the company. Investors are encouraged to stay...

Continue Reading
Nimbello's SyteLine Customer Growth Signals Bright Future Ahead

Updated Category News Views 224

Nimbello's Impressive Growth in the SyteLine Market Nimbello, renowned for its innovative Accounts Payable (AP) automation solutions, has achieved a significant milestone by doubling its customer base among SyteLine users throughout the year. This exciting growth showcases Nimbello's capability and positions it as a leader within the SyteLine ecosystem. Understanding...

Continue Reading
FRE Nicotine Pouches and PBR: A Thrilling Partnership Ahead

Updated Category News Views 169

FRE Nicotine Pouches and PBR: A Thrilling Partnership Ahead In an exciting development for sports enthusiasts, FRE® Nicotine Pouches has joined forces with Professional Bull Riders (PBR) as their official partner for the iconic Unleash The Beast event series. This remarkable multi-year sponsorship marks a significant milestone for FRE, making it their biggest sports...

Continue Reading
ADP Strengthens Workforce Management with WorkForce Software

Updated Category News Views 92

ADP Expands Its Workforce Management Solutions ADP (NASDAQ: ADP), a leading global technology company in human capital management (HCM) solutions, has made a significant move by acquiring WorkForce Software. This strategic acquisition aims to enhance ADP's workforce management offerings and bolster innovation to address the evolving needs of businesses worldwide....

Continue Reading
MiniLuxe Secures Funding through Innovative Private Placement

Updated Category News Views 305

MiniLuxe Announces a Strategic Private Placement MiniLuxe Holding Corp. has recently made headlines by initiating a non-brokered private placement aimed at raising up to $5 million. This move is geared toward furthering the company’s growth trajectory and expanding its footprint in the beauty and self-care industry. Offering Details and Investor Opportunities This...

Continue Reading